BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 5501423)

  • 21. [Immunosuppressive treatment of chronic active hepatitis (author's transl)].
    Vido I; Ranft U; Schmidt FW
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1205-9. PubMed ID: 7428636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of chronic hepatitis with immunosuppressive agents and D-penicillamine].
    Wallnöfer H; Hanusch M
    Wien Med Wochenschr; 1973 Jun; 123(25):402-8. PubMed ID: 4578041
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of severe forms of chronic active hepatitis with high doses of immunosuppressants].
    Aprosina ZG; Krel' PE; Eremeeva EP
    Sov Med; 1985; (5):64-8. PubMed ID: 4049083
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood levels of serotonin and daily urinary excretion of 5-hydroxyindoleacetic acid in patients with chronic aggressive hepatitis.
    Slomka M; Pokora J; Czarnecki J
    Mater Med Pol; 1975; 7(1):20-3. PubMed ID: 1142812
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunosuppressive treatment of the early stages of active or inactive chronic hepatitis: results of a pilot study (author's transl)].
    Vido I; Ranft U; Schmidt FW
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1411-4. PubMed ID: 7449642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proceedings: Behavior of some serum enzymes during a course of immunosuppressive therapy in chronic hepatitis].
    Grasso Caprioli G; Proto C; Albertini A
    Quad Sclavo Diagn; 1973 Mar; 9(1):269-300. PubMed ID: 4151030
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of chronic hepatitis and primary biliary liver cirrhosis with D-penicillamine].
    Mansurov KhKh; Mirodzhov GK; Ladnaia MM
    Klin Med (Mosk); 1981 Feb; 59(2):91-5. PubMed ID: 7289493
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic hepatitis by immunodepressors].
    Magyar I; Kovacs A
    Rev Int Hepatol; 1969; 19(2):147-62. PubMed ID: 4102237
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic glomerulonephritis with imuran].
    Kämpfen P; Hodler J
    Schweiz Med Wochenschr; 1970 Dec; 100(49):2093-100. PubMed ID: 5495326
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppressive long-term treatment of chronic aggressive hepatitis].
    Schimmelpfennig W; Schneider G; Wagner K; Wack R; Lunzenauer K
    Z Gesamte Inn Med; 1975 Dec; 30(24):273 concl. PubMed ID: 1221650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatitis after transfusion hepatitis. Treatment of chronic active liver diseases after transfusion hepatitis with imurel].
    Ernst S
    Med Welt; 1971 Mar; 12():449-53. PubMed ID: 5560079
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunosuppressive therapy of chronic aggressive hepatitis].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G
    Z Gesamte Inn Med; 1973 Jun; 28(12):Suppl:177-8 f. PubMed ID: 4729270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Behavior of immunoglobulins and the histological picture under immunosuppressive therapy in chronic liver diseases].
    Bauch K; Büttner W; Lewicki J; Dempe A; Zimmermann S
    Z Arztl Fortbild (Jena); 1973 Jul; 67(14):705-10. PubMed ID: 4774636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of azathioprin in patients with cirrhosis of the liver.
    Ranek L; Schiödt T; Söborg M; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():49-54. PubMed ID: 4195441
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of Hodgkins disease in the course of active chronic hepatitis treated by immunosuppressive drugs.
    Pirotte JH
    Am J Gastroenterol; 1974 Sep; 62(3):230-9. PubMed ID: 4421900
    [No Abstract]   [Full Text] [Related]  

  • 37. Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease.
    Cederblad G; Korsan-Bengtsen K; Olsson R
    Scand J Gastroenterol; 1976; 11(4):391-6. PubMed ID: 935800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prognostic experiences in the long-term differential therapy of chronic aggressive hepatitides].
    Sensing H; Vollmar F
    Dtsch Z Verdau Stoffwechselkr; 1974; 34(5-6):293-8. PubMed ID: 4220015
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blast transformation of lymphocytes in chronic liver diseases].
    Loginov AS; Osokina LI; Iartseva AM
    Biull Eksp Biol Med; 1972 Aug; 73(8):49-52. PubMed ID: 4635286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.